Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 13.65M | $219.0M | 18.37% | +615.3K | 2026-06-30 |
| Primecap Management Co | 10.18M | $163.0M | 13.70% | -156.7K | 2026-06-30 |
| Bvf Inc | 7.13M | $114.0M | 9.60% | -- | 2026-06-30 |
| Rtw Investments, LP | 6.78M | $109.0M | 9.12% | -- | 2026-06-30 |
| RA Capital Management, L.P. | 5.27M | $84.0M | 7.10% | +377.0K | 2026-06-30 |
| State Street Corp | 4.95M | $79.0M | 6.66% | +602.0K | 2026-06-30 |
| Vanguard Capital Management LLC | 3.28M | $52.0M | 4.41% | +177.2K | 2026-06-30 |
| TCG Crossover Management, LLC | 2.45M | $39.0M | 3.30% | -- | 2026-06-30 |
| Price T Rowe Associates Inc | 2.36M | $37.0M | 3.17% | +796.0K | 2026-06-30 |
| Vanguard Portfolio Management LLC | 2.22M | $35.0M | 2.98% | -1.28M | 2026-06-30 |
